Medicare in the spotlight
Assessing the impact of Inflation Reduction Act drug pricing negotiations on big pharma topline
This morning, the Biden administration unveiled the first 10 drugs that are going to be subject to price “negotiations” between manufacturers and Medicare, according to the Inflation Reduction Act (IRA) that aims to make costly medications more affordable to patients.
As part of the IRA, Medicare obtained the power to directly negotiate drug prices with…